Founded in January 2011 in Basel, Hutman Diagnostics is an in vitro diagnostics product development company, specialized in DNA based applications for the infectious disease market. The trade secret protected probes development process is now supported by a global network of microbiology laboratories that supply patient samples.
Hutman is owned 70% by six private investors. The core team of Hutman has many years of professional experience in management of start-ups and medium sized companies, mostly in the medical field.
Hutman employs in total 15 professionals of which 10 are scientists and of which 5 have a post-doc working experience.
Since February 2015, the company is EN ISO 13485:2012 certified by the notified body TÜV SÜD for Design and Development; More recently, Hutman Diagnostics has successfully passed the surveillance audit on January 14th, 2016.